The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 01, 2020

Filed:

Dec. 21, 2016
Applicant:

Brightgene Bio-medical Technology Co., Ltd., Suzhou, Jiangsu, CN;

Inventors:

Jiandong Yuan, Suzhou, CN;

Fenghua Meng, Jiangsu, CN;

Yan Zou, Jiangsu, CN;

Yuan Fang, Jiangsu, CN;

Zhiyuan Zhong, Jiangsu, CN;

Assignee:

BrightGene Bio-Medical Technology Co., Ltd., Suzhou, Jiangsu Province, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C08G 64/18 (2006.01); C08G 64/30 (2006.01); A61K 49/18 (2006.01); A61K 47/62 (2017.01); A61K 47/68 (2017.01); A61K 9/127 (2006.01); A61K 47/34 (2017.01); C08G 64/02 (2006.01); C08G 64/08 (2006.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
C08G 64/183 (2013.01); A61K 9/1273 (2013.01); A61K 47/34 (2013.01); A61K 47/62 (2017.08); A61K 47/6835 (2017.08); C08G 64/0241 (2013.01); C08G 64/081 (2013.01); C08G 64/305 (2013.01); B82Y 5/00 (2013.01); C08G 2230/00 (2013.01);
Abstract

Disclosed in the present disclosure is a biodegradable amphiphilic polymer containing disulfide in the side chain, a self-crosslinked polymeric vesicle thereof and an application in the targeted therapy of lung cancer. The polymer is obtained by an activity-controllable ring-opening polymerization based on a cyclic carbonate monomer containing a functional group of dithiolane ring, which has a controllable molecular weight and a narrow molecular weight distribution, and does not require processes of protection and deprotection; the polymer obtained by the ring-opening polymerization of the cyclic carbonate monomer of the present disclosure has biodegradability and can be used to control the drug release system, the prepared lung cancer-targeted reduction-sensitive reversibly-crosslinked polymeric vesicle as a nanomedicine carrier supports stable long circulation in vivo. However, it is highly enriched in lung cancer tissues, enter cells efficiently, and rapidly decrosslinks in the cells to release drugs, so as to kill cancer cells with high potency and specificity and inhibit the growth of tumor effectively without causing toxic and side effects.


Find Patent Forward Citations

Loading…